Autophagic therapeutic targeting for Doxorubicin-induced cardiomyopathy
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12165-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 30.06.2026. Verfasst von Noha H Badr und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. noha_hossam@pharm.tanta.edu.eg. Hauptthemen laut MEDLINE: Doxorubicin, Autophagy, Cardiomyopathies. Die Arbeit nennt 105 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. noha_hossam@pharm.tanta.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt.
Zitieren
APA
Badr, N. H., & Khedr, E. G. (2026). Autophagic therapeutic targeting for Doxorubicin-induced cardiomyopathy. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12165-3
Vancouver
Badr NH, Khedr EG. Autophagic therapeutic targeting for Doxorubicin-induced cardiomyopathy. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12165-3
BibTeX
@article{Badr2026,
author = {Badr, Noha H and Khedr, Eman G},
title = {Autophagic therapeutic targeting for Doxorubicin-induced cardiomyopathy},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12165-3}
}
EUVIMED